Conversely, in five of these genes, all clonally mutated patients had mutations that were likely pathogenic (CTNNB1, ELF3, ATM, KMT2E, and PIK3CA), lending stronger support to their candidate gastric cancer driver status. This evidence concerns the gene KMT2E and gastric cancer.